Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IN8BIO, INC. Director's Dealing 2025

Dec 24, 2025

35200_dirs_2025-12-23_53ecd4f8-11df-48b9-95e1-0d57015368a2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2025-12-22

Reporting Person: FAIRBAIRN EMILY (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-12-22 Common Stock A 724637 $1.38 Acquired 724637 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3044 Indirect
Common Stock 923 Indirect

Footnotes

F1: The securities are held by Malcom and Emily Fairbairn 2010 CRUT (the "CRUT"). The Reporting Person is a trustee of the CRUT.

F2: Effective June 3, 2025, the Issuer effected a 1-for-30 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.

F3: The securities are held by Valley High Limited Partnership ("Valley High"). Emily Fairbairn's spouse is the sole managing partner of Valley High and has voting and investment power over the shares held by Valley High.

F4: The securities are held by Emily T. Fairbairn Roth IRA ("Roth IRA"). Emily Fairbairn exercises control over the Roth IRA, and as such, has voting and investment power over the shares held by the Roth IRA.